Microplate reader software is the layer that determines whether instrument data flows reliably into the systems where it can be acted on, or becomes stranded in proprietary files that require manual handling to move. In most laboratories, each microplate reader ships with vendor-specific acquisition and analysis software that manages protocol setup, data capture, curve fitting, and basic reporting — but that software rarely connects natively to the laboratory information management system (LIMS), scientific data management system (SDMS), or electronic laboratory notebook (ELN) that the rest of the lab depends on. The resulting data silos force manual export, reformatting, and transcription steps that introduce errors, slow turnaround, and create compliance risks in regulated environments.
Addressing these gaps through deliberate software integration choices — from data export format selection to bidirectional LIMS connectivity — is one of the highest-leverage operational improvements available to labs running regular plate-based workflows. For context on the broader performance and configuration decisions that govern how microplate readers generate the data that software then handles, see this overview of microplate reader configuration and workflow performance.
Microplate reader software architecture: outputs, export formats, and data structure
Most microplate reader software packages follow a two-component architecture: a reader control interface that manages instrument settings, protocol selection, and run execution, and a data analysis module that performs curve fitting, statistical calculations, and report generation. These two components are sometimes bundled in a single application and sometimes sold or licensed separately. Understanding which component produces the raw data file — and in what format — is the essential first step in planning any integration with downstream systems.
The most commonly supported export formats are comma-separated values (CSV), XML, Microsoft Excel (.xlsx), and ASCII text. CSV and ASCII exports are the most portable — they can be ingested by virtually any LIMS or analysis platform without custom parsing — but they lose the metadata structure that XML preserves, including plate map configuration, protocol parameters, and well-level flags. XML exports provide a richer data record and are better suited to automated LIMS ingestion where traceability of the full measurement context is required. Excel exports are convenient for ad hoc analysis but are unsuitable as the primary format for regulated workflows, as they do not prevent post-export data modification without additional controls.
| Export format | Portability | Metadata retention | LIMS compatibility | Regulatory suitability |
|---|---|---|---|---|
| CSV | Very high | Low | High | Limited without supplementary controls |
| XML | High | High | High | Good; preferred for automated ingestion |
| Excel (.xlsx) | Medium | Medium | Medium | Poor; editable without audit trail |
| ASCII | Very high | Low | High | Limited; typically used for automation scripting |
Connecting microplate reader software to LIMS and analysis platforms
Direct integration between microplate reader software and a LIMS eliminates the manual export-and-upload cycle and creates a continuous, auditable data chain from measurement to result. The most robust integration approach uses an application programming interface (API) connection between the reader software and the LIMS, allowing the LIMS to push worklist files to the reader and pull result files back automatically on run completion. This bidirectional communication removes human handling from the data transfer step entirely and is the architecture recommended for high-throughput laboratories where manual transfer is a practical bottleneck.
Interested in lab tools and techniques?
Where native API integration is not available between a specific reader software and a target LIMS, middleware solutions — software bridges that translate between proprietary instrument data formats and LIMS-compatible structures — provide an intermediate path. The SiLA (Standardization in Lab Automation) 2 protocol is an open industry standard for instrument-to-software communication that is gaining adoption among reader manufacturers and LIMS vendors, and instruments supporting SiLA 2 interfaces can connect to any compatible LIMS without bespoke integration work. Labs evaluating new instrument purchases should treat SiLA 2 compatibility as a selection criterion if LIMS connectivity is a priority, as retrofitting integration to non-standard instruments is substantially more costly than selecting compatible hardware at the outset.
When building integrations, validating the data mapping between reader output fields and LIMS data fields before go-live is critical. Mismatches between well naming conventions, unit formats, or result field names produce silent errors — data that imports successfully but populates the wrong LIMS fields — which are harder to detect and correct than outright import failures. Plate-level quality indicators such as edge effect flags or control well CV values, described in detail in the QA/QC guide to edge effects in microplate reader assays, should be included in the data transfer to give the LIMS visibility into assay run quality, not just raw results.
What 21 CFR Part 11 and Annex 11 require from microplate reader software
Laboratories operating under good manufacturing practice (GMP) or good laboratory practice (GLP) frameworks must ensure that microplate reader software meets the requirements of FDA 21 CFR Part 11, which governs the use of electronic records and electronic signatures in regulated environments. Part 11 compliance requires that software provide user authentication with role-based access controls, a complete and tamper-evident audit trail recording every data creation, modification, and deletion event, and electronic signature functionality tied to individual user credentials. Equivalent requirements apply in European Union-regulated environments under EudraLex Volume 4, Annex 11.
The following software capabilities are mandatory for microplate reader software operating in FDA-regulated workflows under 21 CFR Part 11:
- User authentication: individual login credentials with password controls and automatic session timeouts
- Role-based access: different permission levels for scientists, reviewers, and administrators; no single user can both generate and approve data without a second authorized signatory
- Audit trail: complete, chronological, and uneditable record of all user actions including data entry, modification, deletion, and protocol changes with timestamps and user IDs
- Method locking: finalized protocols cannot be modified without a documented change control process
- Electronic signatures: linked to specific data records, time-stamped, and tied to the signing user's credentials
- Data backup and recovery: automated backup procedures with documented recovery testing
Software that ships with a reader does not automatically satisfy these requirements. Labs must confirm compliance through a formal computer system validation (CSV) process that tests each Part 11 requirement against the installed software version in the actual laboratory environment.
Validating microplate reader software in regulated environments
Computer system validation for microplate reader software follows the standard qualification framework: installation qualification (IQ) confirms the software is installed correctly to vendor specifications; operational qualification (OQ) tests that all software functions perform as intended; and performance qualification (PQ) verifies that the software performs consistently under actual conditions of use with representative assay types and user populations. Each qualification stage generates documentation that becomes part of the instrument's compliance record.
Vendor-supplied validation packages — which many instrument manufacturers provide as a paid service — include prewritten test scripts, acceptance criteria, and summary report templates aligned to the specific software version being validated. These packages reduce the internal effort required for IQ/OQ but do not replace the PQ, which must reflect the laboratory's specific methods and use cases. Risk-based validation, as outlined in FDA guidance on computer system validation, allows labs to focus the depth of testing on functions with direct impact on data integrity and product quality, rather than applying uniform effort across all software features regardless of risk level.
Revalidation is required following any software update that changes functionality, any change to the operating environment, or any significant modification to the assay protocols that the software manages. Maintaining a configuration management log that records the software version, validation status, and date of last qualification for each reader in the lab provides a straightforward compliance reference during audits and accelerates the impact assessment when software changes are proposed.
Getting microplate reader software integration right
Microplate reader software integration is most effective when approached as a laboratory informatics project rather than an instrument procurement decision. Selecting export formats that match LIMS ingestion requirements, establishing API or SiLA 2 connections to eliminate manual data transfer, building Part 11-compliant audit trails into the workflow from day one, and completing formal CSV documentation before entering regulated use together create a data infrastructure that supports both scientific quality and regulatory confidence. Labs that treat software configuration as an afterthought — accepting default export settings and manual workflows because they work in the short term — consistently face larger integration projects and compliance remediation costs as their assay volumes and regulatory requirements grow.
References
- US Food and Drug Administration. Guidance for industry: part 11, electronic records; electronic signatures — scope and application. FDA; 2003. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/part-11-electronic-records-electronic-signatures-scope-and-application
- US Food and Drug Administration. Data integrity and compliance with drug CGMP: questions and answers. FDA; 2018. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/data-integrity-and-compliance-drug-cgmp-questions-and-answers
This article was created with the assistance of Generative AI and has undergone editorial review before publishing.
